NZSTF yields 4.85% · PFE yields 6.13%● Live data
📍 NZSTF pulled ahead of the other in Year 1
Combined, NZSTF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NZSTF + PFE for your $10,000?
NZX Limited operates a stock exchange in New Zealand. The company operates through five segments: Capital Markets Origination, Secondary Markets, Data & Insights, Funds Management, and Wealth Technologies. The Capital Markets Origination segment provides issuer services for current and prospective customers. The Secondary Markets segment provides trading and post-trade services for securities and derivatives markets, as well as provides central securities depository; and acts as a market operator for Fonterra Co-Operative Group, the Electricity Authority, and the Ministry for the Environment. The Data & Insights segment offers information services for the securities and derivatives markets; and analytics for the dairy sector. The Funds Management segment provides superannuation and KiwiSaver, and Smartshares exchange traded funds. The Wealth Technologies segment offers funds administration and custodian services. It also offers NZX Wealth Technologies, a platform that enables advisers and brokers to manage client investments. NZX Limited was founded in 1866 and is headquartered in Wellington, New Zealand.
Full NZSTF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.